Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Evelyn S. Thomas"'
Autor:
John A. Schlechter, DO, Loren C. Tholcke, DO, Trenton G. Lum, DO, Evelyn S. Thomas, DO, Bryn R. Gornick, BS, Gian C. Ignacio, BS, Jessica C. McMichael, MD
Publikováno v:
Journal of the Pediatric Orthopaedic Society of North America, Vol 7, Iss , Pp 100035- (2024)
ABSTRACT: Background: Paralytic agents are occasionally used during the surgical treatment of type III (OTA 13A2) supracondylar humerus fractures (SCHFx) in children depending on surgeon preference. Paralytic agents create a neuromuscular blockade an
Externí odkaz:
https://doaj.org/article/3aff64ff53a74cfcadc74550d907d784
Publikováno v:
European Spine Journal. 32:190-201
To determine if the planned sagittal profile for thoracic kyphosis (TK) restoration was achieved after adolescent idiopathic scoliosis (AIS) surgery using a novel hybrid construct with apical double bands and precontoured patient-specific rods (PSR)
Publikováno v:
Journal of the Pediatric Orthopaedic Society of North America. 5
Publikováno v:
Journal of children's orthopaedics. 16(2)
Purpose: This study examined the volume and characteristics of common surgically treated fractures in children during the COVID-19 pandemic. The worldwide spread of COVID-19 affected the society in numerous ways. Social distancing led to changes in t
Autor:
W. Nathan Holmes, John A. Schlechter, Michael S. Kung, Evelyn S. Thomas, Michael H. French, Hossein Aziz
BackgroundMany treatment decisions in children’s Orthopaedics are based on age. This study determined whether a discrepancy between chronological age (CA) and skeletal age (SA) is dependent on BMI and if overweight or obese children would have an a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::05b125990a8bc8d3ac2ecacf9c53ff43
https://doi.org/10.21203/rs.3.rs-888046/v1
https://doi.org/10.21203/rs.3.rs-888046/v1
Duchenne muscular dystrophy is a common and devastating genetic disease that is primarily caused by exon deletions that create a genetic frameshift in dystrophin. Exon skipping therapy seeks to correct this by masking an exon during the mRNA maturati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9496bc2c27b54bd92a2cedd06476474e